Literature DB >> 13834301

[Hygroton (G 33,182), a new saluretic and diuretic with protracted action].

E G STENGER, H WIRZ, R PULVER.   

Abstract

Keywords:  DIURETICS/pharmacology

Mesh:

Substances:

Year:  1959        PMID: 13834301

Source DB:  PubMed          Journal:  Schweiz Med Wochenschr        ISSN: 0036-7672


× No keyword cloud information.
  9 in total

1.  Therapeutic trial of a new oral diuretic.

Authors:  D S BEANLANDS; S J SHANE
Journal:  Can Med Assoc J       Date:  1961-01-14       Impact factor: 8.262

2.  Long-term experience with chlorthalidone in the management of cardiac edema.

Authors:  J WENER; R FRIEDMAN; A MAYMAN; R SCHUCHER
Journal:  Can Med Assoc J       Date:  1962-07-14       Impact factor: 8.262

3.  Diuretic response to chlorthalidone.

Authors:  A DOUGLAS; R HALL; D B HORN; D N KERR; D T PEARSON; H RICHARDSON
Journal:  Br Med J       Date:  1961-07-22

4.  An oral diuretic with prolonged action.

Authors:  W GROBIN
Journal:  Can Med Assoc J       Date:  1960-02-13       Impact factor: 8.262

5.  3-Amino-1-(3,4-dichloro-alpha-methyl-benzyl)-2-pyrazolin-5-one (Bay g 2821), a potent diuretic from a new substance class.

Authors:  E Möller; H Horstmann; K Meng; D Loew
Journal:  Experientia       Date:  1977-03-15

6.  Pharmacokinetics of chlorthalidone. Dependence of biological half life on blood carbonic anhydrase levels.

Authors:  B A Mulley; G D Parr; R M Rye
Journal:  Eur J Clin Pharmacol       Date:  1980       Impact factor: 2.953

7.  Placental transfer of chlorthalidone and its elimination in maternal milk.

Authors:  B A Mulley; G D Parr; W K Pau; R M Rye; J J Mould; N C Siddle
Journal:  Eur J Clin Pharmacol       Date:  1978-05-17       Impact factor: 2.953

8.  Pharmacokinetic studies with chlorthalidone (Hygroton) in man.

Authors:  W Riess; U C Dubach; D Burckhardt; W Theobald; P Vuillard; M Zimmerli
Journal:  Eur J Clin Pharmacol       Date:  1977-12-16       Impact factor: 2.953

9.  Absolute bioavailability of chlorthalidone in man: a cross-over study after intravenous and oral administration.

Authors:  H L Fleuren; T A Thien; C P Verwey-van Wissen; J M van Rossum
Journal:  Eur J Clin Pharmacol       Date:  1979-02-19       Impact factor: 2.953

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.